Linklaters has advised the LUX MED Group on signing an agreement for the purchase of shares of Lecznice Citomed, which is another significant investment Linklaters has assisted the LUX MED Group with. Completion of the acquisition still requires final approval by the President of the Office of Competition and Consumer Protection.

Lecznice Citomed form one of the largest networks of specialist clinics, occupational medicine and diagnostic laboratories in the Bydgoszcz-Toruń metropolitan area. They include six outpatient clinics and a multi-specialist hospital equipped with modern operating rooms. Citomedic Clinic has been providing medical care services for nearly 30 years, and their team consists of nearly 500 employees.

The LUX MED Group is a leading provider of private health services in Poland and part of the international Bupa group which operates as an insurer and provider of medical services around the world.

The Linklaters Warsaw team was led by Klaudia Królak (counsel) and supported by Jakub Woźniak (senior associate) from the corporate practice. The wider advisory team included Marek Tołcz (associate, corporate), Bartosz Kotylak (trainee, corporate), Szymon Sieniewicz (senior associate, TMT/IP), Małgorzata Szafrańska (associate, real estate), Wojciech Podlasin (managing associate, competition/antitrust), Joanna Koterbska (associate, competition/antitrust), Barbara Wanat (senior associate, competition/antitrust), Tomasz Pleskot (senior associate, energy and infrastructure), Monika Krzyszkowska-Dąbrowska (head of employment) and Łukasz Burakowski (senior associate, employment).